Fact CheckerSign in

NCT04982419RecruitingPhase 2/3

Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

Source: ClinicalTrials.gov · Last updated 15 Dec 2025

Brief summary (registry, in English)

This is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in in patients with congestive heart failure undergoing cardiac catheterization and/or percutaneous coronary intervention.

Status (registry)
Recruiting
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
240 (estimated)
First submitted
26 Jul 2021
Start date
1 Nov 2021
Primary completion date
31 Mar 2028
Lead sponsor
VA Office of Research and Development
NCT number
NCT04982419

What you commit to

  • Study type: Interventional · Phase 2/3
  • Planned participants: 240
  • From 1 Nov 2021 to the primary completion date, 31 Mar 2028
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Kidney transplant
  • Prior exposure to contrast media within 72hrs preceding coronary angiography

Other illness

  • Upper limb peripheral arterial disease
  • Renal disease requiring dialysis

Other

  • Inability to give informed consent
  • Unstable BP (SBP \> 200 or \<80 mmHg) at the time of enrolment
  • Unavailability of at least one arm for RIPC/Sham-RIPC application
  • Pregnancy
  • Prisoner

Who the study is looking for

  • Age 18 years
  • Diagnosis of heart failure with reduced LVEF \<50%
  • Pre-procedure intravenous normal saline fluid restriction status
  • Society for Cardiovascular Angiography and Interventions (SCAI) AKI risk score (\>1%)
  • Referral for coronary angiogram and/or PCI
  • Suspected stable coronary artery disease or acute coronary syndrome

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Coordinator of this site? Confirm its status
DallasUnited StatesRecruiting
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
Coordinator of this site? Confirm its status
PittsburghUnited StatesRecruiting
Hunter Holmes McGuire VA Medical Center, Richmond, VA
Coordinator of this site? Confirm its status
RichmondUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.